N-(1,3-benzoxazol-5-yl)-4-(tert-butylsulfonylamino)benzamide;4-(tert-butylsulfonylamino)-N-[5-(4-fluorophenyl)-1,3,4-thiadiazol-2-yl]benzamide;4-(tert-butylsulfonylamino)-N-(7-methyl-1-benzothiophen-5-yl)benzamide;4-(tert-butylsulfonylamino)-N-[2-methyl-4-(trifluoromethyl)phenyl]benzamide;4-(tert-butylsulfonylamino)-N-pyrimidin-2-ylbenzamide;4-(tert-butylsulfonylamino)-N-[2-(4-sulfamoylphenyl)ethyl]benzamide;4-(tert-butylsulfonylamino)-N-(3,4,5-trimethoxyphenyl)benzamide

C130H150F4N20O27S10 — CID 159646407

About N-(1,3-benzoxazol-5-yl)-4-(tert-butylsulfonylamino)benzamide;4-(tert-butylsulfonylamino)-N-[5-(4-fluorophenyl)-1,3,4-thiadiazol-2-yl]benzamide;4-(tert-butylsulfonylamino)-N-(7-methyl-1-benzothiophen-5-yl)benzamide;4-(tert-butylsulfonylamino)-N-[2-methyl-4-(trifluoromethyl)phenyl]benzamide;4-(tert-butylsulfonylamino)-N-pyrimidin-2-ylbenzamide;4-(tert-butylsulfonylamino)-N-[2-(4-sulfamoylphenyl)ethyl]benzamide;4-(tert-butylsulfonylamino)-N-(3,4,5-trimethoxyphenyl)benzamide

N-(1,3-benzoxazol-5-yl)-4-(tert-butylsulfonylamino)benzamide;4-(tert-butylsulfonylamino)-N-[5-(4-fluorophenyl)-1,3,4-thiadiazol-2-yl]benzamide;4-(tert-butylsulfonylamino)-N-(7-methyl-1-benzothiophen-5-yl)benzamide;4-(tert-butylsulfonylamino)-N-[2-methyl-4-(trifluoromethyl)phenyl]benzamide;4-(tert-butylsulfonylamino)-N-pyrimidin-2-ylbenzamide;4-(tert-butylsulfonylamino)-N-[2-(4-sulfamoylphenyl)ethyl]benzamide;4-(tert-butylsulfonylamino)-N-(3,4,5-trimethoxyphenyl)benzamide (PubChem CID 159646407) has the molecular formula C130H150F4N20O27S10 and a molecular weight of 2821.40 g/mol. Its IUPAC name is N-(1,3-benzoxazol-5-yl)-4-(tert-butylsulfonylamino)benzamide;4-(tert-butylsulfonylamino)-N-[5-(4-fluorophenyl)-1,3,4-thiadiazol-2-yl]benzamide;4-(tert-butylsulfonylamino)-N-(7-methyl-1-benzothiophen-5-yl)benzamide;4-(tert-butylsulfonylamino)-N-[2-methyl-4-(trifluoromethyl)phenyl]benzamide;4-(tert-butylsulfonylamino)-N-pyrimidin-2-ylbenzamide;4-(tert-butylsulfonylamino)-N-[2-(4-sulfamoylphenyl)ethyl]benzamide;4-(tert-butylsulfonylamino)-N-(3,4,5-trimethoxyphenyl)benzamide.

Molecular Properties

• Compound Name: N-(1,3-benzoxazol-5-yl)-4-(tert-butylsulfonylamino)benzamide;4-(tert-butylsulfonylamino)-N-[5-(4-fluorophenyl)-1,3,4-thiadiazol-2-yl]benzamide;4-(tert-butylsulfonylamino)-N-(7-methyl-1-benzothiophen-5-yl)benzamide;4-(tert-butylsulfonylamino)-N-[2-methyl-4-(trifluoromethyl)phenyl]benzamide;4-(tert-butylsulfonylamino)-N-pyrimidin-2-ylbenzamide;4-(tert-butylsulfonylamino)-N-[2-(4-sulfamoylphenyl)ethyl]benzamide;4-(tert-butylsulfonylamino)-N-(3,4,5-trimethoxyphenyl)benzamide
• PubChem CID: 159646407
• Molecular Formula: C130H150F4N20O27S10
• Molecular Weight: 2821.40 g/mol
• Exact Mass: 2818.81
• IUPAC Name: N-(1,3-benzoxazol-5-yl)-4-(tert-butylsulfonylamino)benzamide;4-(tert-butylsulfonylamino)-N-[5-(4-fluorophenyl)-1,3,4-thiadiazol-2-yl]benzamide;4-(tert-butylsulfonylamino)-N-(7-methyl-1-benzothiophen-5-yl)benzamide;4-(tert-butylsulfonylamino)-N-[2-methyl-4-(trifluoromethyl)phenyl]benzamide;4-(tert-butylsulfonylamino)-N-pyrimidin-2-ylbenzamide;4-(tert-butylsulfonylamino)-N-[2-(4-sulfamoylphenyl)ethyl]benzamide;4-(tert-butylsulfonylamino)-N-(3,4,5-trimethoxyphenyl)benzamide
• SMILES: CC(C)(C)S(=O)(=O)Nc1ccc(C(=O)NCCc2ccc(S(N)(=O)=O)cc2)cc1.CC(C)(C)S(=O)(=O)Nc1ccc(C(=O)Nc2ccc3ocnc3c2)cc1.CC(C)(C)S(=O)(=O)Nc1ccc(C(=O)Nc2ncccn2)cc1.CC(C)(C)S(=O)(=O)Nc1ccc(C(=O)Nc2nnc(-c3ccc(F)cc3)s2)cc1.COc1cc(NC(=O)c2ccc(NS(=O)(=O)C(C)(C)C)cc2)cc(OC)c1OC.Cc1cc(C(F)(F)F)ccc1NC(=O)c1ccc(NS(=O)(=O)C(C)(C)C)cc1.Cc1cc(NC(=O)c2ccc(NS(=O)(=O)C(C)(C)C)cc2)cc2ccsc12
• InChI: InChI=1S/C20H26N2O6S.C20H22N2O3S2.C19H21F3N2O3S.C19H19FN4O3S2.C19H25N3O5S2.C18H19N3O4S.C15H18N4O3S/c1-20(2,3)29(24,25)22-14-9-7-13(8-10-14)19(23)21-15-11-16(26-4)18(28-6)17(12-15)27-5;1-13-11-17(12-15-9-10-26-18(13)15)21-19(23)14-5-7-16(8-6-14)22-27(24,25)20(2,3)4;1-12-11-14(19(20,21)22)7-10-16(12)23-17(25)13-5-8-15(9-6-13)24-28(26,27)18(2,3)4;1-19(2,3)29(26,27)24-15-10-6-12(7-11-15)16(25)21-18-23-22-17(28-18)13-4-8-14(20)9-5-13;1-19(2,3)29(26,27)22-16-8-6-15(7-9-16)18(23)21-13-12-14-4-10-17(11-5-14)28(20,24)25;1-18(2,3)26(23,24)21-13-6-4-12(5-7-13)17(22)20-14-8-9-16-15(10-14)19-11-25-16;1-15(2,3)23(21,22)19-12-7-5-11(6-8-12)13(20)18-14-16-9-4-10-17-14/h7-12,22H,1-6H3,(H,21,23);5-12,22H,1-4H3,(H,21,23);5-11,24H,1-4H3,(H,23,25);4-11,24H,1-3H3,(H,21,23,25);4-11,22H,12-13H2,1-3H3,(H,21,23)(H2,20,24,25);4-11,21H,1-3H3,(H,20,22);4-10,19H,1-3H3,(H,16,17,18,20)
• InChIKey: MRAAOHBIWOMLIV-UHFFFAOYSA-N
• XLogP: 25.19
• TPSA: 692.33 Ų
• H-Bond Donors: 15
• H-Bond Acceptors: 34
• Rotatable Bonds: 35
• Heavy Atoms: 191
• Complexity: —

Lipinski Rule of Five

4 violations

Rule	Value
MW ≤ 500	2821.40
LogP ≤ 5	25.19
H-Bond Donors ≤ 5	15
H-Bond Acceptors ≤ 10	34

Frequently Asked Questions

What is the IUPAC name of N-(1,3-benzoxazol-5-yl)-4-(tert-butylsulfonylamino)benzamide;4-(tert-butylsulfonylamino)-N-[5-(4-fluorophenyl)-1,3,4-thiadiazol-2-yl]benzamide;4-(tert-butylsulfonylamino)-N-(7-methyl-1-benzothiophen-5-yl)benzamide;4-(tert-butylsulfonylamino)-N-[2-methyl-4-(trifluoromethyl)phenyl]benzamide;4-(tert-butylsulfonylamino)-N-pyrimidin-2-ylbenzamide;4-(tert-butylsulfonylamino)-N-[2-(4-sulfamoylphenyl)ethyl]benzamide;4-(tert-butylsulfonylamino)-N-(3,4,5-trimethoxyphenyl)benzamide?

The IUPAC name of N-(1,3-benzoxazol-5-yl)-4-(tert-butylsulfonylamino)benzamide;4-(tert-butylsulfonylamino)-N-[5-(4-fluorophenyl)-1,3,4-thiadiazol-2-yl]benzamide;4-(tert-butylsulfonylamino)-N-(7-methyl-1-benzothiophen-5-yl)benzamide;4-(tert-butylsulfonylamino)-N-[2-methyl-4-(trifluoromethyl)phenyl]benzamide;4-(tert-butylsulfonylamino)-N-pyrimidin-2-ylbenzamide;4-(tert-butylsulfonylamino)-N-[2-(4-sulfamoylphenyl)ethyl]benzamide;4-(tert-butylsulfonylamino)-N-(3,4,5-trimethoxyphenyl)benzamide (CID 159646407) is N-(1,3-benzoxazol-5-yl)-4-(tert-butylsulfonylamino)benzamide;4-(tert-butylsulfonylamino)-N-[5-(4-fluorophenyl)-1,3,4-thiadiazol-2-yl]benzamide;4-(tert-butylsulfonylamino)-N-(7-methyl-1-benzothiophen-5-yl)benzamide;4-(tert-butylsulfonylamino)-N-[2-methyl-4-(trifluoromethyl)phenyl]benzamide;4-(tert-butylsulfonylamino)-N-pyrimidin-2-ylbenzamide;4-(tert-butylsulfonylamino)-N-[2-(4-sulfamoylphenyl)ethyl]benzamide;4-(tert-butylsulfonylamino)-N-(3,4,5-trimethoxyphenyl)benzamide.

What is the SMILES notation for N-(1,3-benzoxazol-5-yl)-4-(tert-butylsulfonylamino)benzamide;4-(tert-butylsulfonylamino)-N-[5-(4-fluorophenyl)-1,3,4-thiadiazol-2-yl]benzamide;4-(tert-butylsulfonylamino)-N-(7-methyl-1-benzothiophen-5-yl)benzamide;4-(tert-butylsulfonylamino)-N-[2-methyl-4-(trifluoromethyl)phenyl]benzamide;4-(tert-butylsulfonylamino)-N-pyrimidin-2-ylbenzamide;4-(tert-butylsulfonylamino)-N-[2-(4-sulfamoylphenyl)ethyl]benzamide;4-(tert-butylsulfonylamino)-N-(3,4,5-trimethoxyphenyl)benzamide?

The canonical SMILES for N-(1,3-benzoxazol-5-yl)-4-(tert-butylsulfonylamino)benzamide;4-(tert-butylsulfonylamino)-N-[5-(4-fluorophenyl)-1,3,4-thiadiazol-2-yl]benzamide;4-(tert-butylsulfonylamino)-N-(7-methyl-1-benzothiophen-5-yl)benzamide;4-(tert-butylsulfonylamino)-N-[2-methyl-4-(trifluoromethyl)phenyl]benzamide;4-(tert-butylsulfonylamino)-N-pyrimidin-2-ylbenzamide;4-(tert-butylsulfonylamino)-N-[2-(4-sulfamoylphenyl)ethyl]benzamide;4-(tert-butylsulfonylamino)-N-(3,4,5-trimethoxyphenyl)benzamide is CC(C)(C)S(=O)(=O)Nc1ccc(C(=O)NCCc2ccc(S(N)(=O)=O)cc2)cc1.CC(C)(C)S(=O)(=O)Nc1ccc(C(=O)Nc2ccc3ocnc3c2)cc1.CC(C)(C)S(=O)(=O)Nc1ccc(C(=O)Nc2ncccn2)cc1.CC(C)(C)S(=O)(=O)Nc1ccc(C(=O)Nc2nnc(-c3ccc(F)cc3)s2)cc1.COc1cc(NC(=O)c2ccc(NS(=O)(=O)C(C)(C)C)cc2)cc(OC)c1OC.Cc1cc(C(F)(F)F)ccc1NC(=O)c1ccc(NS(=O)(=O)C(C)(C)C)cc1.Cc1cc(NC(=O)c2ccc(NS(=O)(=O)C(C)(C)C)cc2)cc2ccsc12.

What is the InChIKey of N-(1,3-benzoxazol-5-yl)-4-(tert-butylsulfonylamino)benzamide;4-(tert-butylsulfonylamino)-N-[5-(4-fluorophenyl)-1,3,4-thiadiazol-2-yl]benzamide;4-(tert-butylsulfonylamino)-N-(7-methyl-1-benzothiophen-5-yl)benzamide;4-(tert-butylsulfonylamino)-N-[2-methyl-4-(trifluoromethyl)phenyl]benzamide;4-(tert-butylsulfonylamino)-N-pyrimidin-2-ylbenzamide;4-(tert-butylsulfonylamino)-N-[2-(4-sulfamoylphenyl)ethyl]benzamide;4-(tert-butylsulfonylamino)-N-(3,4,5-trimethoxyphenyl)benzamide?

The InChIKey is MRAAOHBIWOMLIV-UHFFFAOYSA-N. The full InChI is InChI=1S/C20H26N2O6S.C20H22N2O3S2.C19H21F3N2O3S.C19H19FN4O3S2.C19H25N3O5S2.C18H19N3O4S.C15H18N4O3S/c1-20(2,3)29(24,25)22-14-9-7-13(8-10-14)19(23)21-15-11-16(26-4)18(28-6)17(12-15)27-5;1-13-11-17(12-15-9-10-26-18(13)15)21-19(23)14-5-7-16(8-6-14)22-27(24,25)20(2,3)4;1-12-11-14(19(20,21)22)7-10-16(12)23-17(25)13-5-8-15(9-6-13)24-28(26,27)18(2,3)4;1-19(2,3)29(26,27)24-15-10-6-12(7-11-15)16(25)21-18-23-22-17(28-18)13-4-8-14(20)9-5-13;1-19(2,3)29(26,27)22-16-8-6-15(7-9-16)18(23)21-13-12-14-4-10-17(11-5-14)28(20,24)25;1-18(2,3)26(23,24)21-13-6-4-12(5-7-13)17(22)20-14-8-9-16-15(10-14)19-11-25-16;1-15(2,3)23(21,22)19-12-7-5-11(6-8-12)13(20)18-14-16-9-4-10-17-14/h7-12,22H,1-6H3,(H,21,23);5-12,22H,1-4H3,(H,21,23);5-11,24H,1-4H3,(H,23,25);4-11,24H,1-3H3,(H,21,23,25);4-11,22H,12-13H2,1-3H3,(H,21,23)(H2,20,24,25);4-11,21H,1-3H3,(H,20,22);4-10,19H,1-3H3,(H,16,17,18,20).

What are the key properties of N-(1,3-benzoxazol-5-yl)-4-(tert-butylsulfonylamino)benzamide;4-(tert-butylsulfonylamino)-N-[5-(4-fluorophenyl)-1,3,4-thiadiazol-2-yl]benzamide;4-(tert-butylsulfonylamino)-N-(7-methyl-1-benzothiophen-5-yl)benzamide;4-(tert-butylsulfonylamino)-N-[2-methyl-4-(trifluoromethyl)phenyl]benzamide;4-(tert-butylsulfonylamino)-N-pyrimidin-2-ylbenzamide;4-(tert-butylsulfonylamino)-N-[2-(4-sulfamoylphenyl)ethyl]benzamide;4-(tert-butylsulfonylamino)-N-(3,4,5-trimethoxyphenyl)benzamide?

N-(1,3-benzoxazol-5-yl)-4-(tert-butylsulfonylamino)benzamide;4-(tert-butylsulfonylamino)-N-[5-(4-fluorophenyl)-1,3,4-thiadiazol-2-yl]benzamide;4-(tert-butylsulfonylamino)-N-(7-methyl-1-benzothiophen-5-yl)benzamide;4-(tert-butylsulfonylamino)-N-[2-methyl-4-(trifluoromethyl)phenyl]benzamide;4-(tert-butylsulfonylamino)-N-pyrimidin-2-ylbenzamide;4-(tert-butylsulfonylamino)-N-[2-(4-sulfamoylphenyl)ethyl]benzamide;4-(tert-butylsulfonylamino)-N-(3,4,5-trimethoxyphenyl)benzamide has a molecular weight of 2821.40 g/mol, XLogP of 25.19, 35 rotatable bonds, 15 hydrogen bond donors, and 34 hydrogen bond acceptors.

Where does this data come from?

All data for N-(1,3-benzoxazol-5-yl)-4-(tert-butylsulfonylamino)benzamide;4-(tert-butylsulfonylamino)-N-[5-(4-fluorophenyl)-1,3,4-thiadiazol-2-yl]benzamide;4-(tert-butylsulfonylamino)-N-(7-methyl-1-benzothiophen-5-yl)benzamide;4-(tert-butylsulfonylamino)-N-[2-methyl-4-(trifluoromethyl)phenyl]benzamide;4-(tert-butylsulfonylamino)-N-pyrimidin-2-ylbenzamide;4-(tert-butylsulfonylamino)-N-[2-(4-sulfamoylphenyl)ethyl]benzamide;4-(tert-butylsulfonylamino)-N-(3,4,5-trimethoxyphenyl)benzamide is sourced from PubChem (CID 159646407), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).